Paragon Associates & Paragon Associates II Joint Venture’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,000	Closed	-$153K	–	17
2023 Q3	$153K	Buy	+5,000	New	+$153K	0.5%	10